4 completed, 1 active not recruiting. 3 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 3 |
| Phase 1 | 1 | Completed 1 |
Follow adalimumab biosimilar HS016: new trials by email Literature Review of adalimumab biosimilar HS016 trials Research Report on adalimumab biosimilar HS016
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Observational Study, to Assess Treatment Retention of an Adalimumab Biosimilar (Hyrimoz®) in IBD Patients in Real Life Setting Hyrimoz - Inflammatory Bowel Disease | Active not recruiting | Sandoz | 562 | 2023-02-16 | 2026-01-12 | |
| Pharmacokinetic, Efficacy, Safety, and Immunogenicity of AVT02 With Moderate to Severe Chronic Plaque Psoriasis Adalimumab originator, Adalimumab biosimilar - Plaque Psoriasis | Phase 3 | Completed | Alvotech Swiss AG | 567 | 2020-06-30 | 2022-05-04 |
| Effect of Secukinumab on Radiographic Progression in Ankylosing Spondylitis as Compared to GP2017 (Adalimumab Biosimilar) Placebo, GP2017 (adalimumab biosimilar), AIN457 150 mg - Ankylosing Spondylitis | Phase 3 | Completed | Novartis Pharmaceuticals | 859 | 2017-11-30 | 2023-08-21 |
| Phase I Study of HLX3 vs Adalimumab in Chinese Healthy Subjects HLX03, adalimumab - Immune System Disorder | Phase 1 | Completed | Shanghai Henlius Biotech | 220 | 2017-01-12 | 2022-05-09 |
| A Study to Compare FKB327 Long-term Safety, Efficacy and Immunogenicity With Humira® in Rheumatoid Arthritis Patients FKB327, Humira® - Arthritis, Rheumatoid | Phase 3 | Completed | Fujifilm Kyowa Kirin Biologics Co., Ltd. | 645 | 2015-06-10 | 2019-03-26 |
Arthritis (1) · Arthritis, Rheumatoid (1) · Immune System Diseases (1) · Inflammatory Bowel Diseases (1) · Spondylitis, Ankylosing (1)
Alvotech Swiss AG (1) · Fujifilm Kyowa Kirin Biologics Co., Ltd. (1) · Novartis Pharmaceuticals (1) · Sandoz (1) · Shanghai Henlius Biotech (1)
Poland (3) · Russia (3) · Belgium (2) · Canada (2) · Chile (2) · Czechia (2) · France (2) · Germany (2) · Peru (2) · Romania (2) · Spain (2) · Ukraine (2) · United States (2) · Argentina (1) · Australia (1)
Josephine Glover, MD (1) · Steven Feldman, MD, PhD (1) · Yanhua Ding, MD (1)
PMID 31831079, PMID 31983056, PMID 33263165, PMID 33682358, PMID 33978600, PMID 37204631